In a recent meta-analysis which included individual-patient data from five randomized trials, beta-blocker therapy did not ...

Silent heart attacks in women why clear arteries don’t guarantee safety Read ahead to know about MINOCA subtle symptoms and ...

Early substrate-based radiofrequency catheter ablation (RFCA) was associated with reduced risk of implantable cardioverter defibrillator (ICD) therapies, but with no meaningful difference ...

Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. Although it can present with an ...

Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute ...

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug ...

CryoTherapeutics is dedicated to advancing the understanding of high-risk ("vulnerable") plaques and exploring innovative approaches to stabilize them. Although often angiographically non-obstructive, ...

The United States is facing a demographic shift as the population of older adults grows rapidly, with the proportion of ...

A research paper by scientists at the Capital Medical University evaluated sex differences in stroke recurrence among ...

Myocardial ischemia/reperfusion injury (MI/RI) remains a major therapeutic challenge in acute myocardial infarction due to ...

Tailored vitamin D supplementation was associated with reduced risk for incidental myocardial infarction in acute coronary syndrome. (HealthDay News) — For patients with acute coronary syndrome, ...

The main goal in STEMI is to restore blood flow to reduce myocardial injury, Mehran explained. The novel glycoprotein IIb/IIIa inhibitor locks the receptor in its inactive position, which can reduce ...